Sign in

CIK 0001850119

  • Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
842040295
Phone
+1 215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,212
in 5 filings

Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-05-03 Carr Douglas SVP Finance & Operations Sale −257 $3.11 $798 317,323
2024-05-03 Farid Adrienne Chief Operations Officer Sale −913 $3.11 $3K 137,236
2024-04-22 Russotti Gregory Sale 10b5-1 −5,000 $3.10 $15K 297,319
2024-03-07 Pfeiffenberger Brent President and CEO Grant or award +17,425 1,470,704
2024-03-07 Pfeiffenberger Brent President and CEO Grant or award · Stock Option (right to buy) +104,550 104,550
2024-03-07 Carr Douglas SVP Finance & Operations Grant or award +14,000 317,580
2024-03-07 Carr Douglas SVP Finance & Operations Grant or award · Stock Option (right to buy) +81,000 81,000
2024-03-07 Russotti Gregory Grant or award +24,000 302,319
2024-03-07 Russotti Gregory Grant or award · Stock Option (right to buy) +146,000 146,000
2024-03-07 Farid Adrienne Chief Operations Officer Grant or award +24,000 138,149
2024-03-07 Farid Adrienne Chief Operations Officer Grant or award · Stock Option (right to buy) +146,000 146,000
2024-03-07 Levitsky Hyam President of R&D Grant or award +24,000 24,000
2024-03-07 Levitsky Hyam President of R&D Grant or award · Stock Option (right to buy) +146,000 146,000
2024-03-07 Farid Adrienne Chief Operations Officer Exercise or conversion +22,831 $1.03 $24K 136,980
2024-03-07 Farid Adrienne Chief Operations Officer Sale −22,831 $5.14 $117K 114,149
2024-03-07 Farid Adrienne Chief Operations Officer Exercise or conversion · Stock Option (right to buy) −22,831 168,655
2024-03-06 Farid Adrienne Chief Operations Officer Exercise or conversion +30,684 $1.03 $32K 144,833
2024-03-06 Farid Adrienne Chief Operations Officer Sale −30,684 $4.96 $152K 114,149
2024-03-06 Farid Adrienne Chief Operations Officer Exercise or conversion · Stock Option (right to buy) −30,684 191,486
2024-02-16 Farid Adrienne Chief Operations Officer Exercise or conversion +485 $1.03 $500 114,634

Page 7 of 12 · 233 trades